Literature DB >> 16513358

Pyranocoumarin, a novel anti-TB pharmacophore: synthesis and biological evaluation against Mycobacterium tuberculosis.

Ze-Qi Xu1, Krzysztof Pupek, William J Suling, Livia Enache, Michael T Flavin.   

Abstract

Pyranocoumarin compounds were identified to embody a novel and unique pharmacophore for anti-TB activity. A systematic approach was taken to investigate the structural characteristics. Focused libraries of compounds were synthesized and evaluated for their anti-TB activity in primary screening assays. Compounds shown to be active were further determined for MIC and MBC values. Three of the four bactericidal compounds (16, 17c, and 18f) were amino derivatives, with MIC values of 16 microg/mL and respective MBC values of 32, 32, and 64 microg/mL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16513358     DOI: 10.1016/j.bmc.2006.02.017

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

1.  Pyranocoumarins isolated from Peucedanum praeruptorum Dunn suppress lipopolysaccharide-induced inflammatory response in murine macrophages through inhibition of NF-κB and STAT3 activation.

Authors:  Peng-Jiu Yu; Hong Jin; Jun-Yan Zhang; Guang-Fa Wang; Jing-Rong Li; Zheng-Guang Zhu; Yuan-Xin Tian; Shao-Yu Wu; Wei Xu; Jia-Jie Zhang; Shu-Guang Wu
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

2.  Synthesis of novel pyrano[2,3-f]chromene-dione derivatives using phosphoric acid-functionalized silica-coated Fe3O4 nanoparticles as a new reusable solid acid nanocatalyst.

Authors:  Iman Sedighimehr; Bahador Karami; Mahnaz Farahi; Mosadegh Keshavarz
Journal:  Mol Divers       Date:  2022-08-01       Impact factor: 3.364

3.  4,4-Dimethyl-2-tosyl-1,2,3,3a,4,11b-hexa-hydro-11H-pyrrolo[3,4-c]pyrano[5,6-c]chromen-11-one 0.125-hydrate.

Authors:  K Chinnakali; D Sudha; M Jayagobi; R Raghunathan; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-10-31

4.  14-Eth-oxy-4,6-dimethyl-9-phenyl-8,12-dioxa-4,6-diaza-tetra-cyclo-[8.8.0.0(2,7).0(13,18)]octa-deca-2(7),13,15,17-tetra-ene-3,5,11-trione.

Authors:  G Jagadeesan; D Kannan; M Bakthadoss; S Aravindhan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-12-12

5.  rac-Dimethyl 5-oxo-2-[(2,4,4-trimethyl-pentan-2-yl)amino]-4,5-dihydro-pyrano[3,2-c]chromene-3,4-dicarboxyl-ate.

Authors:  S Antony Inglebert; Yuvaraj Arun; K Sethusankar; Paramasivam T Perumal
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-06-23

6.  14-Meth-oxy-4,6-dimethyl-9-phenyl-8,12-dioxa-4,6-di-aza-tetra-cyclo-[8.8.0.0(2,7).0(13,18)]octa-deca-2(7),13,15,17-tetra-ene-3,5,11-trione.

Authors:  G Jagadeesan; S Jayashree; D Kannan; M Bakthadoss; S Aravindhan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-07-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.